A detailed history of Fountainhead Am, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fountainhead Am, LLC holds 1,452 shares of ABBV stock, worth $247,348. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,452
Previous 1,517 4.28%
Holding current value
$247,348
Previous $260,000 10.0%
% of portfolio
0.06%
Previous 0.06%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$163.84 - $199.33 $10,649 - $12,956
-65 Reduced 4.28%
1,452 $286,000
Q2 2024

Jul 26, 2024

SELL
$154.79 - $180.76 $16,098 - $18,799
-104 Reduced 6.42%
1,517 $260,000
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $2,077 - $2,367
13 Added 0.81%
1,621 $295,000
Q4 2023

Feb 01, 2024

BUY
$137.6 - $154.97 $2,339 - $2,634
17 Added 1.07%
1,608 $249,000
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $212,541 - $246,048
1,591 New
1,591 $237,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $5,639 - $6,495
-39 Reduced 2.58%
1,475 $235,000
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $209,401 - $251,127
1,514 New
1,514 $244,000
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $1,651 - $2,099
12 Added 0.93%
1,308 $200,000
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $171,046 - $212,220
1,296 New
1,296 $210,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fountainhead Am, LLC Portfolio

Follow Fountainhead Am, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fountainhead Am, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fountainhead Am, LLC with notifications on news.